Indeed, co-culturing donor IFN-DCs with glioblastoma cells (Figure 2g) resulted in more than a 3-fold increase in the number of DCs expressing CD107a (CD107a+CFSE+ cells), which represents a lytic granule membrane marker. The gene discussed is LAMP1; the disease is glioblastoma.